Arrest of S-phase progression is impaired in Fanconi anemia cells

被引:67
作者
Sala-Trepat, M [1 ]
Rouillard, D [1 ]
Escarceller, M [1 ]
Laquerbe, A [1 ]
Moustacchi, E [1 ]
Papadopoulo, D [1 ]
机构
[1] Inst Curie Rech, UMR 218 CNRS, Sect Rech, F-75248 Paris 05, France
关键词
Fanconi anemia; psoralen photolesions; DNA cross-links; repair; cell cycle;
D O I
10.1006/excr.2000.4994
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Fanconi anemia (FA) is an inherited cancer-susceptibility disorder, characterized by genomic instability, hypersensitivity to DNA cross-linking agents, and a prolonged G2 phase of the cell cycle. We observed a marked dose-dependent accumulation of FA cells in the G2 compartment after treatment with 4,5',8-trimethylpsoralen (Me(3)Pso) in combination with 365 nm irradiation. Using bivariate DNA distribution methodology, we determined the proportion of replicating and arresting S-phase cells and observed that, whereas normal cells arrested DNA replication in the presence of Me(3)Pso cross-links and monoadducts, FA lymphoblasts failed to arrest DNA synthesis. Taken together, the above data suggest that, in response to damage induced by DNA cross-linking agents, the S-phase checkpoint is inefficient in FA cells. This would lead to accumulation of secondary lesions, such as single- and double-strand breaks and gaps. The prolonged time in G2 phase seen in FA cells therefore exists in order to allow the cells to remove lesions which accumulated during the preceding abnormal S phase, (C) 2000 Academic Press.
引用
收藏
页码:208 / 215
页数:8
相关论文
共 37 条
[1]   SUSCEPTIBILITY OF FANCONIS ANEMIA FIBROBLASTS TO CHROMOSOME-DAMAGE BY CARCINOGENS [J].
AUERBACH, AD ;
WOLMAN, SR .
NATURE, 1976, 261 (5560) :494-496
[2]  
AUERBACH AD, 1997, GENETIC BASIS HUMAN, P317
[3]  
AVERBECK D, 1988, CANCER RES, V48, P2015
[4]   FANCONI-ANEMIA - CHROMOSOME BREAKAGE AND CELL-CYCLE STUDIES [J].
BERGER, R ;
LECONIAT, M ;
GENDRON, MC .
CANCER GENETICS AND CYTOGENETICS, 1993, 69 (01) :13-16
[5]   Is Fanconi anemia caused by a defect in the processing of DNA damage? [J].
Buchwald, M ;
Moustacchi, E .
MUTATION RESEARCH-DNA REPAIR, 1998, 408 (02) :75-90
[6]   Molecular biology of Fanconi anemia: Implications for diagnosis and therapy [J].
DAndrea, AD ;
Grompe, M .
BLOOD, 1997, 90 (05) :1725-1736
[7]   The Fanconi anaemia group G gene FANCG is identical with XRCC9 [J].
de Winter, JP ;
Waisfisz, Q ;
Rooimans, MA ;
van Berkel, CGM ;
Bosnoyan-Collins, L ;
Alon, N ;
Carreau, M ;
Bender, O ;
Demuth, I ;
Schindler, D ;
Pronk, JC ;
Arwert, F ;
Hoehn, H ;
Digweed, M ;
Buchwald, M ;
Joenje, H .
NATURE GENETICS, 1998, 20 (03) :281-283
[8]   THE CELL-CYCLE OF LYMPHOCYTES IN FANCONI ANEMIA [J].
DUTRILLAUX, B ;
AURIAS, A ;
DUTRILLAUX, AM ;
BURIOT, D ;
PRIEUR, M .
HUMAN GENETICS, 1982, 62 (04) :327-332
[9]  
Garcia-Higuera I, 1999, MOL CELL BIOL, V19, P4866
[10]  
GRUENERT DC, 1985, CANCER RES, V45, P5399